Patients
cardiovascular and cerebrovascular diseases, diabetes, liver disease, death, tumor
TUMOR, OVARIAN METASTASIS, METASTASIS, RECURRENCE, DISEASE, STD, LYMPH NODE METASTASIS, MALIGNANT TUMOR
We included 1081 women with stage IA‐IVB CC who received treatment at the Sun Yat‐sen Memorial Hospital of Sun Yat‐sen University in China from June 2013 to December 2019. After excluding pregnant patients (Study selection process.Information regarding clinicopathological features and follow‐up were retrieved from the electronic medical records. Interrogated clinicopathological features included age at diagnosis, FIGO stage, menopause, ovarian metastasis (resection), parity, history of STD, history of malignant tumor, diabetes, liver disease, cardiovascular and cerebrovascular diseases, histological type, tumor differentiation, PLN metastasis status, para‐aortic lymph node metastasis status, tumor size, vascular invasion, cervical junction invasion, cervical myometrial invasion, parametrial invasion, vaginal fornix involvement. Follow‐up data were collected regarding occurrence of and time to disease recurrence, metastasis, and death. DFS was defined as time interval from surgical excision to disease recurrence or death, and OS was defined as the interval from diagnosis to death or last follow‐up. The study was conducted in accordance with the ethical standards laid down in the Declaration of Helsinki. All participants have signed informed consent, and institutional Review Board approval was obtained from the Medical Ethics Board at the Sun Yat‐sen Memorial Hospital.